Cargando…
Targeting Toxoplasma gondii CPSF3 as a new approach to control toxoplasmosis
Toxoplasma gondii is an important food and waterborne pathogen causing toxoplasmosis, a potentially severe disease in immunocompromised or congenitally infected humans. Available therapeutic agents are limited by suboptimal efficacy and frequent side effects that can lead to treatment discontinuatio...
Autores principales: | Palencia, Andrés, Bougdour, Alexandre, Brenier‐Pinchart, Marie‐Pierre, Touquet, Bastien, Bertini, Rose‐Laurence, Sensi, Cristina, Gay, Gabrielle, Vollaire, Julien, Josserand, Véronique, Easom, Eric, Freund, Yvonne R, Pelloux, Hervé, Rosenthal, Philip J, Cusack, Stephen, Hakimi, Mohamed‐Ali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5331205/ https://www.ncbi.nlm.nih.gov/pubmed/28148555 http://dx.doi.org/10.15252/emmm.201607370 |
Ejemplares similares
-
Toxoplasma gondii TgIST co-opts host chromatin repressors dampening STAT1-dependent gene regulation and IFN-γ–mediated host defenses
por: Gay, Gabrielle, et al.
Publicado: (2016) -
The Toxoplasma effector TEEGR promotes parasite persistence by modulating NF-kB signalling via EZH2
por: Braun, Laurence, et al.
Publicado: (2019) -
Target Identification of an Antimalarial Oxaborole Identifies AN13762 as an Alternative Chemotype for Targeting CPSF3 in Apicomplexan Parasites
por: Bellini, Valeria, et al.
Publicado: (2020) -
Characterization of a Toxoplasma effector uncovers an alternative GSK3/β-catenin-regulatory pathway of inflammation
por: He, Huan, et al.
Publicado: (2018) -
Toxoplasma gondii, a plea for a thorough investigation of its oncogenic potential
por: Dupont, D., et al.
Publicado: (2023)